Paper41516111
Anticancer Effects of Sacha Inchi (Plukenetia volubilis) Shell Extract on Colon Cancer Cells: Integrated GC-MS, LC-MS, Transcriptomic, and Proteomic Analyses.
Osotprasit S and 8 others. Int J Mol Sci, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Anticancer Effects of Sacha Inchi (Plukenetia volubilis) Shell Extract on Colon Cancer Cells: Integrated GC-MS, LC-MS, Transcriptomic, and Proteomic Analyses. Papers, record 41516111. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41516111
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anticancer Effects of Sacha Inchi (Plukenetia volubilis) Shell Extract on Colon Cancer Cells: Integrated GC-MS, LC-MS, Transcriptomic, and Proteomic Analyses.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Plant Extracts | Major topic |
| Colonic Neoplasms | Major topic |
| Euphorbiaceae | Major topic |
| Transcriptome | Major topic |
| Antineoplastic Agents, Phytogenic | Major topic |
| Humans | |
| Proteomics | |
| Cell Movement | |
| Cell Line, Tumor | |
| Gas Chromatography-Mass Spectrometry | |
| Gene Expression Regulation, Neoplastic | |
| Chromatography, Liquid | |
| Gene Expression Profiling | |
| Epithelial-Mesenchymal Transition | |
| Cell Proliferation |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| N41A650402 | National Research Council of Thailand | PubMed |
Source PubMed
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 41226554 | Anti-Metastatic Effects of Plukenetia volubilis (Sacha Inchi) Husk Extract via EGFR and EMT Pathways and Other Antitumor Effects in Colon Cancer. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226554 | PubMed |
| 2 | 29064740 | Organophosphorus flame retardants (PFRs) and phthalates in floor and road dust from a manual e-waste dismantling facility and adjacent communities in Thailand. | J Environ Sci Health A Tox Hazard Subst Environ Eng | 2018 | https://conductscience.org/library/papers/29064740 | PubMed |
| 3 | 15785001 | Anti-invasive activity of niacin and trigonelline against cancer cells. | Biosci Biotechnol Biochem | 2005 | https://conductscience.org/library/papers/15785001 | PubMed |
| 4 | 20133591 | Cancer stem cells from colorectal cancer-derived cell lines. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20133591 | PubMed |
| 5 | 8797003 | Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. | Enzyme Protein | 1996 | https://conductscience.org/library/papers/8797003 | PubMed |
| 6 | 33417959 | Molecular mechanisms of action of Trehalose in cancer: A comprehensive review. | Life Sci | 2021 | https://conductscience.org/library/papers/33417959 | PubMed |
| 7 | 34731811 | Sacha inchi (Plukenetia volubilis L.): An emerging source of nutrients, omega-3 fatty acid and phytochemicals. | Food Chem | 2022 | https://conductscience.org/library/papers/34731811 | PubMed |
| 8 | 34451596 | The Unique Substance, Lidocaine and Biological Activity of the Dioscorea Species for Potential Application as a Cancer Treatment, Natural Pesticide and Product. | Plants (Basel) | 2021 | https://conductscience.org/library/papers/34451596 | PubMed |
| 9 | 38484571 | Natural compound Byakangelicin suppresses breast tumor growth and motility by regulating SHP-1/JAK2/STAT3 signal pathway. | Biochem Biophys Res Commun | 2024 | https://conductscience.org/library/papers/38484571 | PubMed |
| 10 | 37637038 | Molecular mechanism of palmitic acid and its derivatives in tumor progression. | Front Oncol | 2023 | https://conductscience.org/library/papers/37637038 | PubMed |
| 11 | 17260186 | Sclareol induces apoptosis in human HCT116 colon cancer cells in vitro and suppression of HCT116 tumor growth in immunodeficient mice. | Apoptosis | 2007 | https://conductscience.org/library/papers/17260186 | PubMed |
| 12 | 35999582 | Alpha-linolenic acid inhibits hepatocellular carcinoma cell growth through Farnesoid X receptor/β-catenin signaling pathway. | Nutr Metab (Lond) | 2022 | https://conductscience.org/library/papers/35999582 | PubMed |
| 13 | 30941958 | Antiproliferative effects of propofol and lidocaine on the colon adenocarcinoma microenvironment. | J BUON | 2019 | https://conductscience.org/library/papers/30941958 | PubMed |
| 14 | 30285678 | N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer. | BMC Cancer | 2018 | https://conductscience.org/library/papers/30285678 | PubMed |
| 15 | 25429772 | Presence of phthalate derivatives in the essential oils of a medicinal plant Achillea tenuifolia. | Daru | 2014 | https://conductscience.org/library/papers/25429772 | PubMed |
| 16 | 24042735 | Epigenetic and genetic features of 24 colon cancer cell lines. | Oncogenesis | 2013 | https://conductscience.org/library/papers/24042735 | PubMed |
| 17 | 30262429 | Lidocaine inhibits proliferation and induces apoptosis in colorectal cancer cells by upregulating mir-520a-3p and targeting EGFR. | Pathol Res Pract | 2018 | https://conductscience.org/library/papers/30262429 | PubMed |
| 18 | 32905277 | Lidocaine promotes autophagy of SH-SY5Y cells through inhibiting PI3K/AKT/mTOR pathway by upregulating miR-145. | Toxicol Res (Camb) | 2020 | https://conductscience.org/library/papers/32905277 | PubMed |
| 19 | 30188700 | Cell Motility Facilitated by Mono(2-ethylhexyl) Phthalate via Activation of the AKT-β-Catenin-IL-8 Axis in Colorectal Cancer. | J Agric Food Chem | 2018 | https://conductscience.org/library/papers/30188700 | PubMed |
| 20 | 22138224 | Inhibition of MT1-MMP activity using functional antibody fragments selected against its hemopexin domain. | Int J Biochem Cell Biol | 2012 | https://conductscience.org/library/papers/22138224 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42353321 | Molecular Effects of Parkia speciosa Hassk. Empty Pod Extract in Colon Cancer: A Transcriptomic and Proteomic Perspective. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353321 | PubMed |
| 41752208 | Suppressive Potential of Ethanolic Extracts of Parkia speciosa Hassk. Empty Pods Against Colon Cancer Cell Migration and Invasion. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41752208 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41516111
GET https://conductscience.org/api/papers/v1/41516111/references?page=2